Indica Labs and Lunit announce a strategic alliance for seamless integrated digital pathology AI workflows
Indica Labs and Lunit announced an agreement to provide a fully interoperable solution between Indica Labs' HALO AP image management software platform and Lunit's suite of AI pathology products. The combined solution is already in use at Guardant Health.
Lunit SCOPE PD-L1 NSCLC is a CE-marked AI solution for detecting and analyzing PD-L1 TPS, a cancer biomarker. The solution may assist pathologists by minimizing interpretation variability and allowing better prediction of treatment outcomes for NSCLC patients, as demonstrated in study findings published in the European Journal of Cancer.
Indica Labs developed the HALO AP platform specifically to meet the needs of anatomic pathology labs worldwide. The CE-IVD certified HALO AP platform supports a wide range of tissue-based workflows, including primary diagnosis, secondary consults, clinical trials, synoptic reporting, quantitative analytics and AI. One of the key advantages of HALO AP is the seamless integration of AI solutions into the workflow, whether developed by Indica Labs or third parties. To simplify integration, a HALO AP software development kit (SDK) is available to all algorithm developers. With HALO AP, users can utilize algorithms in an automated, stepwise workflow that can be locked, secured and audited to prevent tampering or misuse.
Lunit SCOPE PD-L1 NSCLC can be activated in the HALO AP user interface. Analysis progress, all results and visual markup images can be reviewed in HALO AP, so users never have to leave the viewer or shift between systems. With HALO AP's built-in workflow management tools, an algorithm can automatically run upon slide intake so that the results are ready for the pathologist to review the case. By integrating Lunit's powerful AI solutions into HALO AP, pathologists and researchers can benefit from the combined capabilities of both platforms, providing them with advanced tools to help them make more informed decisions.
